Aesther Healthcare Acquisition closed its IPO of 10 million units price at $10 each.
The underwriters partially exercised their over-allotment option for an additional 500,000 units at the time of the closing. As a result, gross proceeds of the offering are $105 million, less expenses.
Units trade on the Nasdaq under AEHAU. Once the securities begin separate trading, shares and warrants are expected to list under AEHA and AEHAW.
The SPAC intends to focus on the pharmaceutical and medical device sectors.
EF Hutton was sole book running manager for the offering. Read more.
